WilmerHale Advises Phantom Neuro in $6M Expanded Seed Financing

WilmerHale Advises Phantom Neuro in $6M Expanded Seed Financing

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Critical industry insight and formidable strength across key practices.

On September 12, 2022, Phantom Neuro, a first-of-its-kind neurotech startup specializing in robotic orthopedic technologies, announced that it secured $6 million in its second round of funding. The round, which was led by new investor Time BioVentures, brings the company’s total funding to $9.5 million and included participation from returning investors LionBird Ventures, Draper Associates and Breakout Ventures. Phantom Neuro intends to utilize the new funds to advance its mission of enabling lifelike control of robotic orthopedic technologies like prosthetic limbs and exoskeletons.

The WilmerHale team advising Phantom Neuro was led by Adam Freiman and Brendan Catalano.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel